Extremadura is the fourth region with fewer cases of monkeypox, 22

Extremadura has counted until this Friday 22 people infected with monkeypox, one of whom had to be admitted although without serious criteria, while in the national total the cases amount to 4,942 people, of whom 139 have been hospitalized and two died

Extremadura is the fourth least affected community.

The Second Vice President of the Council and Minister of Health and Social Services, José María Vergeles, made public the number of infections in the region through a message on social networks, where he also said that “whether or not it is serious, the stigma It cannot and should not silence this disease, it must be treated well”.

According to data updated by the Ministry of Health, Spain remains the first European country -includes nearly half of the 11,536 positives detected on the continent- and the second in the world – only preceded by the United States, which exceeds 7,100 – the most affected by this alert declared an international public health emergency at the end of July.

According to Health, since Tuesday 365 new infections have been reported; out of 4,436 cases for which this information exists and 2.8% required hospitalization.

The deceased, meanwhile, remains in two young men, one from the Valencian Community, another 31-year-old boy from Córdoba.

Nine deaths have been confirmed worldwide, in addition to two in Spain, three in Nigeria, two in the Central African Republic, one in Ghana and one in India, although the WHO is investigating other deaths that may be linked to this. epidemic.

Madrid and Catalonia

By communities, Madrid continues to be the one with the highest number of cases with 1,817, ahead of Catalonia (1,558) and, much further, Andalusia (661), Valencian Community (284); Basque Country (130); Canary Islands (118) and Balearic Islands (111).

They are followed by Galicia (71); Aragon (47) and Asturias (47); Castile and Leon (41); Castile-La Mancha (36); Murcia (26); Extremadura (22); Cantabria (18); Navarre (12) and La Rioja, with 4.

The vast majority of patients notified to the surveillance system in Spain (Sivies), 4,863 are men and 79 are women whose age varies between 10 months and 88 years, the median remaining at 37 years.

Of those with clinical information, six in ten had an anogenital rash (59.4%) and just over half (55.1%) had fever. They also had rashes in other locations (51.8% neither ano-genital nor bucco-buccal) and lymphadenopathy (50.7%).

These symptoms were followed by asthenia (32.8%); muscle pain (25.2%); headache (23.5%); oral rash (19.9%) and sore throat (13.3%).

According to the report, 237 cases had complications throughout their clinical process with other symptoms, the most common being canker sores and secondary bacterial infections.

Eight out of ten infected people (3,943, 79.78%) are men who have sex with men (MSM). The most likely mechanism of transmission in 2,287 cases for which this information is available was close contact during sexual intercourse in 80.6% of cases and close non-sexual contact in 9.1%.

There is also data on participation in massive events in 3,152 cases; among them, 646 attended one in the dates before the onset of symptoms.

7,000 additional vaccines

Meanwhile, Spain is still awaiting the arrival of 7,000 more vaccines than the 11,400 it acquired through Hera, the European Health Emergency Preparedness and Response Authority, in addition to the 200 others that it purchased from a third State.

The Minister of Health indicated last Tuesday that they would be by the end of this week or the beginning of the next, although yesterday she specified that they would be “in the coming weeks”. They will join the 5,000 that communities have already started playing on demand.

The simian virus vaccination plan considers pre-exposure prophylaxis in people with high-risk and post-exposure practices of close contacts of confirmed cases, especially those at high risk of severe disease such as children, pregnant women and immunocompromised people.

Also for health and laboratory personnel in contact with positives that have impacted the use of their protective equipment (PPE).

Leave a Comment